In breast cancer, overexpression of Mena promotes the proliferation and invasion of tumor cells, but deletion of Mena inhibits the metastasis of breast cancer and upregulated Mena increases drug resistance to breast cancer (22, 23). The gene discussed is ENAH; the disease is breast carcinoma.